Myobloc Atrophy Study

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Spasticity Secondary to Either a Disorder or TraumaSpinal Cord Injury (SCI)Brain InjuryTumorStroke
Interventions
DRUG

Botox

Treatment group will receive 100 units of BOTOX and subjects will receive 1-3 injections per muscle at each visit.

DRUG

MYOBLOC

Treatment group will receive 5,000 units of MYOBLOC and subjects will receive 1-3 injections per muscle at each visit.

Trial Locations (1)

20007

Medstar Georgetown University Hospital, Washington D.C.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Solstice Neurosciences

INDUSTRY

lead

Georgetown University

OTHER

NCT02052024 - Myobloc Atrophy Study | Biotech Hunter | Biotech Hunter